FLASCO presents From Testing to Treatment: Connecting NGS Workflows to Timely Clinical Action.
This educational webinar will explore practical strategies for optimizing next-generation sequencing (NGS) workflows and translating molecular testing results into timely, informed treatment decisions for patients with metastatic non-small cell lung cancer (mNSCLC). Faculty will examine electronic medical record (EMR) and testing workflows designed to reduce turnaround times and improve the identification of actionable biomarkers. Through peer perspectives on implementation science, participants will gain insights into navigating and interpreting NGS reports across varying formats, integrating molecular findings with patient-specific factors, and applying evidence-based guidelines to support personalized treatment planning. Designed for oncology healthcare professionals involved in the diagnosis and treatment of patients with mNSCLC, this program will provide actionable strategies for bridging the gap between molecular testing and clinical decision-making.
